⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
GOSS
Gossamer Bio to Participate in Upcoming Investor Conferences
businesswire.com
GOSS
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update
businesswire.com
GOSS
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
prnewswire.com
GOSS
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
businesswire.com
GOSS
Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025
businesswire.com
GOSS